Gregory L. Moore

Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions

Gregory L. Moore, Hsing Chen, Sher Karki et al. · mAbs · 2010 · 257 citations · Full text

Pharmacy, Immunology, Oncology +17

Creating multiple-crossover DNA libraries independent of sequence identity

Stefan Lutz, Marc Ostermeier, Gregory L. Moore et al. · Proceedings of the National Academy of Sciences · 2001 · 157 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +17

Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies

Seung Y. Chu, Igor Voštiar, Sher Karki et al. · Molecular Immunology · 2008 · 155 citations

Life Sciences, Cell Biology, Immunology +11

Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell–recruiting Antibody Optimized for Cytotoxicity and Cytokine Release

Christina L. Zuch de Zafra, Flordeliza Fajardo, Wendy Zhong et al. · Clinical Cancer Research · 2019 · 127 citations

Life Sciences, Immunology, Oncology +17

A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens

Gregory L. Moore, Cristina Bautista, Erik Pong et al. · mAbs · 2011 · 103 citations · Full text

Pharmacy, Biotechnology, Immunology +17